How should a female patient with dementia in a memory care unit who has hallucinations, delusions, exit‑seeking behavior, and other behavioral disturbances be treated?

Treatment of Hallucinations, Delusions, Exit-Seeking, and Behavioral Disturbances in Dementia

Begin with person-centered nonpharmacological interventions as first-line treatment, and reserve antipsychotic medications only for severe, dangerous symptoms or significant patient distress after nonpharmacological approaches have been tried. 1

Initial Assessment and Documentation

Before initiating any treatment, conduct a systematic evaluation:

• Assess symptom characteristics: Document the type, frequency, severity, pattern, and timing of hallucinations, delusions, exit-seeking behavior, and agitation 1
• Identify modifiable contributors: Specifically evaluate for pain, infection, constipation, medication side effects, environmental triggers, and unmet needs (hunger, thirst, toileting) 1, 2
• Use quantitative measures: Implement standardized tools to track response to treatment objectively 1
• Create a comprehensive treatment plan: Document both nonpharmacological and pharmacological interventions in writing 1

First-Line: Nonpharmacological Interventions

Nonpharmacological strategies are the preferred first-line approach except in emergency situations where there is imminent danger 2. These interventions conceptualize behaviors as stemming from unmet needs and environmental factors rather than purely as disease symptoms.

Specific Strategies for Exit-Seeking Behavior:

• Establish a "no-fail" environment with appropriate cues about time and place 3
• Address the underlying need driving the exit-seeking (looking for home, searching for a person, boredom, overstimulation) 4
• Provide calm, compassionate redirection rather than confrontation 4
• Consider structured activities and day care programs, which have demonstrated effectiveness 5

General Behavioral Management:

• Limit goals and provide reassurance to reduce agitation 3
• Reduce environmental overload and overstimulation 2
• Restrict daytime naps to improve nighttime sleep disturbances 3
• Educate and support family/caregivers as the cornerstone of management 3

Critical caveat: While guidelines strongly recommend nonpharmacological approaches first, they often fail in real-world settings due to time constraints and lack of provider training 2. However, you must still document that these approaches were reviewed before proceeding to medications 1.

Pharmacological Treatment: When and How

Indications for Antipsychotic Use

Antipsychotics should only be used when symptoms are severe, dangerous, and/or cause significant distress to the patient 1. For this patient with hallucinations, delusions, and exit-seeking behavior, antipsychotics may be appropriate if:

• The exit-seeking poses safety risks (elopement, injury)
• The hallucinations/delusions cause significant patient distress
• Nonpharmacological interventions have been inadequate

Pre-Treatment Requirements

Before initiating antipsychotics, you must:

1. Conduct risk-benefit discussion: Meet with the patient (if feasible) and surrogate decision maker to discuss the black box warning of increased mortality and morbidity in elderly patients with dementia 1, 6
2. Document the discussion: Include potential benefits versus risks of stroke, falls, sedation, and death
3. Obtain informed consent from the appropriate decision maker

Medication Selection and Dosing

If risk-benefit assessment favors antipsychotic use, start with a second-generation antipsychotic at a low dose and titrate to the minimum effective dose 1:

• Risperidone has the most evidence for aggression and psychosis in dementia 7, 8
• Start at 0.25-0.5 mg daily and titrate slowly
• Alternative: Consider other second-generation antipsychotics, though evidence is more limited 6

For agitation specifically: Citalopram (SSRI) is conditionally recommended as an alternative, particularly in Alzheimer's disease 7

Monitoring and Reassessment

• Use quantitative measures to track response objectively 1
• After 4 weeks: If no clinically significant response at an adequate dose, taper and withdraw the medication 1
• Monitor for side effects: If significant side effects occur, review risk-benefit and consider tapering 1
• If positive response: Discuss ongoing treatment with family/surrogate, reviewing initial goals, observed benefits, side effects, and risks of continued exposure 1

Additional Considerations

Cognitive Enhancers

If not already prescribed, consider cholinesterase inhibitors (donepezil) or memantine, which show moderate efficacy for general behavioral symptoms and may help with hallucinations, particularly in Lewy body dementia 7, 5. These have better safety profiles than antipsychotics.

Common Pitfalls to Avoid

1. Don't skip nonpharmacological assessment: Even if you plan to use medications, document what environmental/behavioral interventions were considered 1
2. Don't use antipsychotics indefinitely: These are meant for time-limited use with regular reassessment 1
3. Don't ignore pain: Unrecognized pain is a major driver of behavioral disturbances in dementia 1
4. Don't forget caregiver burden: The wife's distress may be enhancing the patient's symptoms in circular fashion 9; addressing caregiver needs is therapeutic

Discharge Planning

Approximately 50% of patients with very severe challenging behavior can be discharged to regular dementia special care units after appropriate treatment in specialized settings 10. The goal is stabilization sufficient for return to a less restrictive environment.

The evidence strongly supports a stepwise approach: assess thoroughly, try nonpharmacological interventions, use medications judiciously when needed for safety, monitor closely, and taper when possible 1, 2, 7.